Latest News about VCEL
Recent news which mentions VCEL
Vericel Earnings Perspective: Return On Capital Employed
February 28, 2023
Tickers
VCEL
From Benzinga
Earnings Scheduled For February 23, 2023
February 23, 2023
From Benzinga
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
January 25, 2023
From Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
From Benzinga
FDA Approves MediWound's NexoBrid For Burn Treatment
December 30, 2022
From Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
From Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
From Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
November 10, 2022
From Benzinga
The Bull Market Is Still Alive
August 29, 2022
From InvestorPlace
The Bull Market Is Still Alive
August 29, 2022
From InvestorPlace
From InvestorPlace
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
June 14, 2022
From Benzinga
Earnings Scheduled For May 4, 2022
May 04, 2022
From Benzinga
88 Biggest Movers From Yesterday
February 25, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 24, 2022
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.